You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Chemotherapy

The guidelines and other documents available here provide recommendations on safe and effective chemotherapy for people with cancer in Ontario.

Displaying Guidelines

141 Items

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Document Status: Education and Information
ID: 6-7 Version 2
Version: 2

Jun 2013

The Use of FOLFIRINOX as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

Document Status: Archived
ID: 2-18

Jun 2011

The Use of Leucovorin in Colorectal Cancer

Document Status: Archived
ID: 12-17

Feb 2016

The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer

Document Status: In-Review
ID: 7-22

Aug 2015

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-3

Feb 2021

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-2
Version: N/A

Jan 2020

Treatment of Acute Myeloid Leukemia in Older Patients

Document Status: Archived
ID: 6-14

Dec 2008

Treatment with Fludarabine for Patients with Follicular and Other Low Grade Non-Hodgkin's Lymphoma and Waldenstrom's Macroglobulinemia

Document Status: Archived
ID: 6-2
Version: 2

Aug 2013

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Document Status: Archived
ID: 12-3

Jan 2003

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer

Document Status: Current
ID: GL 1-22-A
Version: 2

Jul 2022

Use of Adjuvant Chemotherapy Following Cystectomy in Patients with Deep Muscle-Invasive Transitional Cell Carcinoma of the Bladder

Document Status: Archived
ID: 3-2-1

Oct 2012

Use of Chemotherapy in Advanced Unresectable or Metastatic Transitional Cell Carcinoma of the Bladder or Urothelium

Document Status: Archived
ID: 3-12

Nov 2011